Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEDCE trial of prophylactic subanesthetic esketamine for prevention of postoperative delirium after cardiac surgery in older adults
ChiCTR2300074395Phase 4Recruiting
- Sponsor
- Fuwai Central China Cardiovascular Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative delirium (POD) (2 arms), sponsored by Fuwai Central China Cardiovascular Hospital. Primary endpoint: Postoperative delirium. Started Aug 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300074395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074395.